The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWalker Crips Regulatory News (WCW)

Share Price Information for Walker Crips (WCW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 22.50
Bid: 22.00
Ask: 23.00
Change: 0.00 (0.00%)
Spread: 1.00 (4.545%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 22.50
WCW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity and Total Voting Rights

25 May 2018 07:00

RNS Number : 2428P
Walker Crips Group plc
25 May 2018
 

25 May 2018

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Walker Crips Group plc

Issue of Equity and Total Voting Rights

Further to its announcement of 9 March 2015 regarding the acquisition of Barker Poland Asset Management LLP ("BPAM"), Walker Crips Group plc ("Walker Crips" or the "Company"), the financial services group with activities including stockbroking, investment and wealth management, announces that an aggregate of 175,439 new ordinary shares in the capital of Company (the "BPAM Shares") have been issued and allotted to the Sellers of BPAM in order to satisfy the Company's obligations in connection with the payment of the year three BPAM deferred consideration. The BPAM business has met the targets required to trigger a payment by the Company of the full amount of the 3rd and final payment of deferred consideration.

Under the terms of the agreement for the acquisition of BPAM, deferred consideration may become due in each of the first three years following completion, dependent on the results achieved by the legacy BPAM Business. All deferred consideration due under the agreement is payable 90% in cash and 10% in new ordinary shares in the Company. The cash element of the year three deferred consideration has been satisfied from the Company's existing cash resources.

In addition, a further 234,159 new ordinary shares (the "Additional Shares" and, together with the BPAM Shares, the "Shares") have been issued and allotted to personnel associated with the Company in order to meet contractual commitments made by the Company as part of the ongoing recruitment of investment advisers and expansion of its client base. It has been agreed that the onward sale of these Additional Shares will be restricted for the period until 21 March 2021 at the earliest.

Application is being made to the UK Listing Authority for the Shares (which, in aggregate, amount to 409,598 Shares) to be admitted to the Official List, and application is being made to the London Stock Exchange for the Shares to be admitted to trading on its main market for listed securities. It is expected that such admission will become effective at 8.00 am on 31 May 2018 ("Admission"). In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the Company notifies the market that following Admission, the Company's issued share capital will consist of 43,327,328 ordinary shares with a nominal value of 6 2/3 pence each ("Ordinary Shares") with each Ordinary Share carrying the right to one vote. The Company holds 750,000 Ordinary Shares in Treasury. Therefore, following Admission, the Company will have 42,577,328 Ordinary Shares in issue (excluding treasury shares) and, accordingly, the total number of voting rights in the Company will be 42,577,328.

The above figure 42,577,328 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Walker Crips Group plc under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

For further information contact:

Walker Crips Group plc +44 (0) 20 3100 8000

Bridgette Campbell, Media Relations

Cantor Fitzgerald Europe   +44 (0) 20 7894 7000

Marc Milmo / Will Goode

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKMGZKDDDGRZM
Date   Source Headline
29th May 201912:01 pmRNSDirector/PDMR Shareholding
21st May 20195:15 pmRNSDirector/PDMR Shareholding
8th May 201911:30 amRNSDirector/PDMR Shareholding
27th Mar 20196:30 pmRNSDirector/PDMR Shareholding
13th Mar 20195:53 pmRNSReplacement Director/PDMR Shareholding
13th Mar 201912:53 pmRNSDirector/PDMR Shareholding
7th Mar 20194:52 pmRNSDirector/PDMR Shareholding
4th Mar 20198:44 amRNSDirector/PDMR Shareholding
1st Mar 20193:56 pmRNSDirector/PDMR Shareholding
26th Feb 20194:00 pmRNSTrading Update
12th Feb 20194:56 pmRNSDirector / PDMR Shareholdings
30th Jan 20197:00 amRNSBoard changes
17th Dec 201812:00 pmRNSDirector/PDMR Shareholding
27th Nov 20188:36 amRNSHalf-year Report - Replacement
27th Nov 20187:00 amRNSResults for the six months ended 30 September 2018
29th Oct 201811:25 amRNSDirector/PDMR Shareholding
11th Oct 20182:53 pmRNSDirector/PDMR Shareholding
20th Sep 201811:10 amRNSDirector/PDMR Shareholding
14th Sep 20185:24 pmRNSDirector/PDMR Shareholding
5th Sep 20184:33 pmRNSResult of AGM
31st Jul 20184:08 pmRNSFinal Results
8th Jun 20183:28 pmRNSDirector/PDMR Shareholding
25th May 20187:00 amRNSIssue of Equity and Total Voting Rights
26th Apr 20188:20 amRNSHolding(s) in Company
18th Apr 20185:34 pmRNSDirector/PDMR Shareholding
21st Mar 20187:00 amRNSHolding(s) in Company
6th Mar 20185:36 pmRNSHolding(s) in Company
19th Feb 20183:30 pmRNSDirector/PDMR Shareholding
9th Feb 20184:55 pmRNSDirectorate Change
4th Jan 201810:10 amRNSDirector/PDMR Shareholding
21st Dec 201710:10 amRNSDirector/PDMR Shareholding
13th Dec 201712:31 pmRNSHolding(s) in Company
13th Dec 201712:30 pmRNSDirector / PDMR Shareholdings
11th Dec 20178:24 amRNSDirector/PDMR Shareholding
1st Dec 20175:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20177:00 amRNSHalf-year Report
13th Oct 20177:00 amRNSIssue of Equity and Total Voting Rights
6th Sep 20174:02 pmRNSResult of AGM
31st Aug 20177:00 amRNSBoard changes
18th Jul 20177:00 amRNSAnnual Financial Results
22nd May 20171:41 pmRNSDirector/PDMR Shareholding
12th May 20177:00 amRNSIssue of Equity and Total Voting Rights
24th Mar 20175:09 pmRNSDirectorate Change
15th Mar 20177:00 amRNSSale of Fund Management Contract
9th Mar 20175:53 pmRNSHolding(s) in Company
9th Mar 20175:52 pmRNSDirector/PDMR Shareholding
9th Mar 20177:00 amRNSIssue of Equity and Total Voting Rights
3rd Mar 20173:13 pmRNSForm 8.3 - Clinical Computing
3rd Mar 20173:11 pmRNSForm 8.3 - Clinical Computing re Ian Amiee
21st Dec 201612:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.